Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation

被引:19
作者
Friedrich, R
Panizzi, P
Kawabata, SI
Bode, W
Bock, PE
Fuentes-Prior, P
机构
[1] Vanderbilt Univ, Sch Med, Dept Pathol, Med Ctr N, Nashville, TN 37232 USA
[2] Max Planck Inst Biochem, Proteinase Res Grp, D-82152 Martinsried, Germany
[3] Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan
[4] Hosp Santa Cruz & San Pablo, CSIC, Inst Catala Ciencies Cardiovasc, Cardiovasc Res Ctr, E-08025 Barcelona, Spain
关键词
D O I
10.1074/jbc.M507957200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Staphylocoagulase (SC) is a protein secreted by the human pathogen, Staphylococcus aureus, that activates human prothrombin (ProT) by inducing a conformational change. SC-bound ProT efficiently clots fibrinogen, thus bypassing the physiological blood coagulation pathway. The crystal structure of a fully active SC fragment, SC-(1-325), bound to human prethrombin 2 showed that the SC-(1-325) N terminus inserts into the Ile(16) pocket of prethrombin 2, thereby inducing expression of a functional catalytic site in the cognate zymogen without peptide bond cleavage. As shown here, SC-(1-325) binds to bovine and human ProT with similar affinity but activates the bovine zymogen only very poorly. By contrast to the similar to 2-fold difference in chromogenic substrate kinetic constants between human thrombin and the SC-(1-325)center dot human (pro) thrombin complexes, SC-(1-325)center dot bovine ProT shows a 3,500-fold lower k(cat)/K-m compared with free bovine thrombin, because of a 47-fold increase in K-m and a 67-fold decrease in k(cat). The SC-(1-325)center dot bovine ProT complex is similar to 5,800-fold less active compared with its human counterpart. Comparison of human and bovine fibrinogen as substrates of human and bovine thrombin and the SC-( 1 325)center dot(pro)thrombin complexes indicates that the species specificity of SC-(1-325) cofactor activity is determined primarily by differences in conformational activation of bound ProT. These results suggest that the catalytic site in the SC-(1-325)center dot bovine ProT complex is incompletely formed. The current crystal structure of SC-( 1 325)center dot bovine thrombin reveals that SC would dock similarly to the bovine proenzyme, whereas the bovine (pro)thrombin-characteristic residues Arg(144) and Arg(145) would likely interfere with insertion of the SCN terminus, thus explaining the greatly reduced activation of bovine ProT.
引用
收藏
页码:1188 / 1195
页数:8
相关论文
共 33 条
  • [1] Characterization of proexosite I on prothrombin
    Anderson, PJ
    Nesset, A
    Dharmawardana, KR
    Bock, PE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) : 16428 - 16434
  • [2] THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT
    BODE, W
    MAYR, I
    BAUMANN, U
    HUBER, R
    STONE, SR
    HOFSTEENGE, J
    [J]. EMBO JOURNAL, 1989, 8 (11) : 3467 - 3475
  • [3] BODE W, 1992, PROTEIN SCI, V1, P426
  • [4] BODE W, 1992, THROMBIN STRUCTURE F
  • [5] Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase
    Boxrud, PD
    Verhamme, IM
    Bock, PE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) : 36633 - 36641
  • [6] Coupling of conformational and proteolytic activation in the kinetic mechanism of plasminogen activation by streptokinase
    Boxrud, PD
    Bock, PE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) : 36642 - 36649
  • [7] Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1
  • [8] REFINED 2.3-ANGSTROM X-RAY CRYSTAL-STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA - A STARTING POINT FOR IMPROVING ANTITHROMBOTICS
    BRANDSTETTER, H
    TURK, D
    HOEFFKEN, HW
    GROSSE, D
    STURZEBECHER, J
    MARTIN, PD
    EDWARDS, BFP
    BODE, W
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1992, 226 (04) : 1085 - 1099
  • [9] Castellino F J, 1976, Methods Enzymol, V45, P244
  • [10] COLLEN D, 1993, J BIOL CHEM, V268, P8284